These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9333066)

  • 41. Concentrations of cefodizime in bronchial secretions after single intravenous administration.
    Pacheco Y; Pirollet B; Taviot B; Coppere B; Perrin-Fayolle M; Dagrosa EE; Damm D
    Arzneimittelforschung; 1993 Aug; 43(8):924-6. PubMed ID: 8216455
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacokinetics of ceftriaxone administered by the intravenous, intramuscular or subcutaneous routes to dogs.
    Rebuelto M; Albarellos G; Ambros L; Kreil V; Montoya L; Bonafine R; Otero P; Hallu R
    J Vet Pharmacol Ther; 2002 Feb; 25(1):73-6. PubMed ID: 11874531
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of plasma and free tissue levels of ceftriaxone in rats by microdialysis.
    Kovar A; Dalla Costa T; Derendorf H
    J Pharm Sci; 1997 Jan; 86(1):52-6. PubMed ID: 9002459
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cefotaxime twice daily versus ceftriaxone once daily. A randomized controlled study in patients with serious infections.
    Simmons BP; Gelfand MS; Grogan J; Craft B
    Diagn Microbiol Infect Dis; 1995; 22(1-2):155-7. PubMed ID: 7587031
    [TBL] [Abstract][Full Text] [Related]  

  • 45. HPTLC determination of ceftriaxone, cefixime and cefotaxime in dosage forms.
    Eric-Jovanovic S; Agbaba D; Zivanov-Stakic D; Vladimirov S
    J Pharm Biomed Anal; 1998 Dec; 18(4-5):893-8. PubMed ID: 9919994
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical pharmacokinetics and therapeutic efficacy of ceftriaxone in Chinese adults.
    Zhu Z; Wang AX; Li Y
    Chemotherapy; 1997; 43(3):218-26. PubMed ID: 9142464
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparative pharmacokinetic evaluation of ceftriaxone and cefotaxime in coincidence for short-term antimicrobial prophylaxis in surgery.
    Periti P; Mazzei T; Costantini A; Rizzo M; Gasparri F; Scarselli G; Alaimo E; Finistorchi O; Nicoletti P
    Chemioterapia; 1984 Oct; 3(5):305-9. PubMed ID: 6099758
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Characterization of peripheral-compartment kinetics of antibiotics by in vivo microdialysis in humans.
    Müller M; Haag O; Burgdorff T; Georgopoulos A; Weninger W; Jansen B; Stanek G; Pehamberger H; Agneter E; Eichler HG
    Antimicrob Agents Chemother; 1996 Dec; 40(12):2703-9. PubMed ID: 9124826
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Pharmacokinetic and clinical studies on cefodizime in obstetrics and gynecology].
    Cho N; Fukunaga K; Kunii K
    Jpn J Antibiot; 1989 Oct; 42(10):2069-81. PubMed ID: 2607597
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Intraosseous administration of antibiotics: same-dose comparison with intravenous administration in the weanling pig.
    Pollack CV; Pender ES; Woodall BN; Parks BR
    Ann Emerg Med; 1991 Jul; 20(7):772-6. PubMed ID: 2064098
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Clinical and laboratory study of cefodizime (Modivid) in prophylaxis and treatment of surgical patients].
    Khlebnikov EP; Iakovlev VP; Elagina LV; Kubyshkin VA; Krutikov MG; Pavlova MV; Grishina IA; Alekseev AA; Kurochkina AI
    Antibiot Khimioter; 1998; 43(6):16-9. PubMed ID: 9644529
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A comparison of the prophylactic efficacy of ceftriaxone and cefotaxime in abdominal surgery.
    Woodfield JC; Van Rij AM; Pettigrew RA; van der Linden AJ; Solomon C; Bolt D
    Am J Surg; 2003 Jan; 185(1):45-9. PubMed ID: 12531444
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antibiotics and production of granulocyte-macrophage colony-stimulating factor by human bronchial epithelial cells in vitro. A comparison of cefodizime and ceftriaxone.
    Pacheco Y; Hosni R; Dagrosa EE; Gormand F; Guibert B; Chabannes B; Lagarde M; Perrin-Fayolle M
    Arzneimittelforschung; 1994 Apr; 44(4):559-63. PubMed ID: 8011012
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Disposition of ceftriaxone in rat: application of a pharmacokinetic-protein binding model and comparison with cefotaxime.
    Hakim L; Bourne DW; Triggs EJ
    Xenobiotica; 1989 Aug; 19(8):815-22. PubMed ID: 2815824
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Activity of third-generation cephalosporins in human blood.
    Shah PM; Jaenisch E
    Clin Ther; 1983; 6(1):72-8. PubMed ID: 6325006
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Pharmacokinetics of cefodizime in patients undergoing hemodialysis].
    Itagaki N; Hasegawa H; Sakaguchi M; Oono T; Iwamoto I; Horiuchi H; Tsujino M; Takahashi K; Imada A; Horiuchi A
    Jpn J Antibiot; 1991 Dec; 44(12):1392-6. PubMed ID: 1798074
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cefotaxime versus ceftriaxone for the treatment of nosocomial pneumonia. Results of a multicenter study.
    Shah PM; Stille W
    Diagn Microbiol Infect Dis; 1995; 22(1-2):171-2. PubMed ID: 7587035
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of the probability of target attainment between ceftriaxone and cefepime in the cerebrospinal fluid and serum against Streptococcus pneumoniae.
    Lodise TP; Nau R; Kinzig M; Jones RN; Drusano GL; Sörgel F
    Diagn Microbiol Infect Dis; 2007 Aug; 58(4):445-52. PubMed ID: 17512154
    [TBL] [Abstract][Full Text] [Related]  

  • 59. beta-lactam antibiotics in the treatment of neuroborreliosis in children: preliminary results.
    Millner MM; Thalhammer GH; Dittrich P; Spork KD; Brunner M; Georgopoulos A
    Infection; 1996; 24(2):174-7. PubMed ID: 8740117
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Study on the penetration of ceftriaxone into cerebrospinal fluid].
    Hattori T; Kobayashi H; Uno T
    Jpn J Antibiot; 1996 Aug; 49(8):813-7. PubMed ID: 9053536
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.